Autoimmune myelopathy, neural autoantibody positive (Q100591): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(One intermediate revision by the same user not shown)
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 17:19, 16 August 2026

Autoimmune myelopathy, an immune mediated diseases of the spinal cord, seropositive for neural autoantibodies. Associated neural autoantibodies include: AQP4-IgG (aquaporin-4 autoantibodies); CRMP5 (anti-CV2: western blot detection) collapsin response mediator protein 5); GAD65 (glutamic acid decarboxylase-65 antibodies); MOG (myelin associated glycoprotein autoantibodies).
Language Label Description Also known as
default for all languages
ID_222408969
    English
    Autoimmune myelopathy, neural autoantibody positive
    Autoimmune myelopathy, an immune mediated diseases of the spinal cord, seropositive for neural autoantibodies. Associated neural autoantibodies include: AQP4-IgG (aquaporin-4 autoantibodies); CRMP5 (anti-CV2: western blot detection) collapsin response mediator protein 5); GAD65 (glutamic acid decarboxylase-65 antibodies); MOG (myelin associated glycoprotein autoantibodies).

      Statements

      CID11:ID_222408969
      0 references
      dki-india-ID_222408969
      0 references
      Concluído
      0 references
      15 August 2026
      0 references